Top Markets
Coin of the day
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited

TaiGen Biopharmaceuticals Holdings Limited

4157
Rangering i aksjer #18445
TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm... TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm dedicated to pioneering innovative treatments for life-altering diseases. Its robust development pipeline features several key assets. Among these is Taigexyn (Nemonoxacin), a non-fluorinated quinolone antibiotic currently being advanced for the treatment of various bacterial infections, including community-acquired pneumonia and diabetic foot infections. The company is also progressing Burixafor, a stem cell mobilizer with applications in stem cell transplantation and chemosensitization. Further contributing to its portfolio is TG-1000, an antiviral medication designed to combat influenza A, B, and the avian influenza H7N9 strain. Additionally, Furaprevir, a hepatitis C virus (HCV) protease inhibitor, is under development for managing chronic hepatitis C. Established in 2001, TaiGen Biopharmaceuticals maintains its headquarters in Taipei City, Taiwan.
Aksjekurs
$0.27824149
Markedsverdi
$198.06M
Endring (1 dag)
-1.24%
Endring (1 år)
-11.01%
Land
TW
Handel TaiGen Biopharmaceuticals Holdings Limited (4157)

Kategori

Historikk for aksjesplitt for TaiGen Biopharmaceuticals Holdings Limited (4157)
Aksjen TaiGen Biopharmaceuticals Holdings Limited (symbol: 4157) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Sep 03, 2026.
Én 4157-aksje kjøpt før Sep 03, 2026 tilsvarer i dag 0 4157-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH